Trial Site Detail

 

Drug:
Imatinib + BKM120
Trial:
A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Fred Hutchinson Cancer Research Center

     
Seattle , WA 98104
USA

 

Principal Investigator:
Robin L Jones
Contact:
Reina Hibbert rhibbert@seattlecca.org
Activation Status of this Site:
Closed
Notes about this Site:
Fred Hutchinson Cancer Research Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.